NeuroBo Pharmaceuticals, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$1.42 | -$1.42 | -$1.42 |
Q2 2024 | 1 | -$0.82 | -$0.82 | -$0.82 |
Q3 2024 | 0 | -$0.81 | -$0.81 | -$0.81 |
NeuroBo Pharmaceuticals, Inc. Earnings Date And Information
NeuroBo Pharmaceuticals, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-1.85 earnings per share for the quarter, missing analysts' consensus estimates of $-1.38 by $0.47. The company had revenue of 0 for the quarter and had revenue of 7,000 for the year. NeuroBo Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.46 diluted earnings per share) and currently has a price-to-earnings ratio of -0.57. NeuroBo Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
NeuroBo Pharmaceuticals, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/14/2024 | Q2 2024 | -$1.38 | -$1.85 | -0.47 | $0 | $0 |
05/09/2024 | Q1 2024 | -$0.95 | -$1.32 | -0.37 | $0 | |
03/28/2024 | Q4 2023 | -$0.78 | -$1.05 | -0.27 | $4,000 | |
11/13/2023 | Q3 2023 | -$0.11 | -$0.75 | -0.64 | $0 | |
08/09/2023 | Q2 2023 | -$0.13 | -$0.15 | -0.02 | $0 | |
05/12/2023 | Q1 2023 | -$0.63 | -$0.53 | 0.1 | $0 | |
03/30/2023 | Q4 2022 | -$1.20 | $0.31 | 1.51 | $0 | |
11/14/2022 | Q3 2022 | -$40.88 | -$3.51 | 37.37 | $0 | |
08/12/2022 | Q2 2022 | -$40.84 | -$3.72 | 37.12 | $0 | |
05/13/2022 | Q1 2022 | -$38.44 | -$3.24 | 35.2 | $0 | |
03/31/2022 | Q4 2021 | -$6.16 | $0 | |||
11/15/2021 | Q3 2021 | -$43.24 | -$4.66 | 38.58 | $0 | |
08/16/2021 | Q2 2021 | -$36.04 | -$5.35 | 30.69 | $0 | |
05/17/2021 | Q1 2021 | -$38.44 | -$4.61 | 33.83 | $0 | |
04/15/2021 | Q4 2020 | -$35.63 | $0 | |||
11/13/2020 | Q3 2020 | -$40.84 | -$5.58 | 35.26 | $0 | |
08/11/2020 | Q2 2020 | -$64.86 | -$4.39 | 60.47 | $0 | |
05/20/2020 | Q1 2020 | -$3.00 | -$9.06 | -6.06 | $0 | |
03/30/2020 | Q4 2019 | -$6.00 | -$193.47 | -187.47 | $0 | |
11/08/2019 | Q3 2019 | -$19.92 | $0 |
NeuroBo Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is NeuroBo Pharmaceuticals, Inc.'s earnings date?
NeuroBo Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to NeuroBo Pharmaceuticals, Inc.'s earnings conference call?
The conference call for NeuroBo Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read NeuroBo Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for NeuroBo Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does NeuroBo Pharmaceuticals, Inc. generate each year?
NeuroBo Pharmaceuticals, Inc. (:NRBO) has a recorded annual revenue of $7,000.
-
How much profit does NeuroBo Pharmaceuticals, Inc. generate each year?
NeuroBo Pharmaceuticals, Inc. (:NRBO) has a recorded net income of $7,000. NeuroBo Pharmaceuticals, Inc. has generated $-2.46 earnings per share over the last four quarters.
-
What is NeuroBo Pharmaceuticals, Inc.'s price-to-earnings ratio?
NeuroBo Pharmaceuticals, Inc. (:NRBO) has a price-to-earnings ratio of -0.57 and price/earnings-to-growth ratio is -0.01.